Corcept Therapeutics Inc (CORT)
27.61
-0.22
(-0.79%)
USD |
NASDAQ |
May 16, 10:24
Corcept Therapeutics Market Cap: 2.875B for May 16, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 15, 2024 | 2.897B |
May 14, 2024 | 2.880B |
May 13, 2024 | 2.866B |
May 10, 2024 | 2.815B |
May 09, 2024 | 2.769B |
May 08, 2024 | 2.644B |
May 07, 2024 | 2.549B |
May 06, 2024 | 2.496B |
May 03, 2024 | 2.553B |
May 02, 2024 | 2.609B |
May 01, 2024 | 2.486B |
April 30, 2024 | 2.428B |
April 29, 2024 | 2.433B |
April 26, 2024 | 2.374B |
April 25, 2024 | 2.312B |
April 24, 2024 | 2.340B |
April 23, 2024 | 2.388B |
April 22, 2024 | 2.316B |
April 19, 2024 | 2.383B |
April 18, 2024 | 2.353B |
April 17, 2024 | 2.388B |
April 16, 2024 | 2.429B |
April 15, 2024 | 2.404B |
April 12, 2024 | 2.441B |
April 11, 2024 | 2.473B |
Date | Value |
---|---|
April 10, 2024 | 2.471B |
April 09, 2024 | 2.644B |
April 08, 2024 | 2.516B |
April 05, 2024 | 2.617B |
April 04, 2024 | 2.606B |
April 03, 2024 | 2.668B |
April 02, 2024 | 2.638B |
April 01, 2024 | 2.678B |
March 28, 2024 | 2.608B |
March 27, 2024 | 2.621B |
March 26, 2024 | 2.562B |
March 25, 2024 | 2.553B |
March 22, 2024 | 2.536B |
March 21, 2024 | 2.562B |
March 20, 2024 | 2.527B |
March 19, 2024 | 2.510B |
March 18, 2024 | 2.517B |
March 15, 2024 | 2.405B |
March 14, 2024 | 2.450B |
March 13, 2024 | 2.505B |
March 12, 2024 | 2.532B |
March 11, 2024 | 2.459B |
March 08, 2024 | 2.447B |
March 07, 2024 | 2.420B |
March 06, 2024 | 2.384B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.123B
Minimum
May 31 2019
3.567B
Maximum
Feb 08 2021
2.286B
Average
2.369B
Median
Market Cap Benchmarks
Ultragenyx Pharmaceutical Inc | 3.472B |
Alnylam Pharmaceuticals Inc | 18.45B |
Catalyst Pharmaceuticals Inc | 1.971B |
United Therapeutics Corp | 12.03B |
XOMA Corp | 287.59M |
Market Cap Related Metrics
PE Ratio | 26.05 |
PS Ratio | 5.820 |
PEG Ratio | 0.8899 |
Price to Book Value | 5.247 |
Price to Free Cash Flow | 24.41 |
Price | 27.61 |
Earnings Yield | 3.84% |
PEGY Ratio | 0.8899 |
Operating PE Ratio | 24.99 |
Normalized PE Ratio | 26.05 |